Tango Therapeutics, Inc. (TNGX)
24.52
+0.64
(+2.68%)
USD |
NASDAQ |
Aug 24, 16:00
24.52
0.00 (0.00%)
After-Hours: 19:54
Tango Therapeutics Debt to Equity Ratio : 0.0312 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0312 |
| March 31, 2026 | 0.0837 |
| December 31, 2025 | 0.097 |
| September 30, 2025 | 0.2172 |
| June 30, 2025 | 0.2594 |
| March 31, 2025 | 0.2216 |
| December 31, 2024 | 0.1829 |
| September 30, 2024 | 0.1642 |
| June 30, 2024 | 0.1528 |
| March 31, 2024 | 0.1446 |
| December 31, 2023 | 0.1538 |
| September 30, 2023 | 0.1428 |
| June 30, 2023 | 0.1873 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.182 |
| December 31, 2022 | 0.1649 |
| September 30, 2022 | 0.1491 |
| June 30, 2022 | 0.0021 |
| March 31, 2022 | 0.0034 |
| December 31, 2021 | 0.0044 |
| September 30, 2021 | 0.0197 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.2042 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 1.020 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Revolution Medicines, Inc. | 0.4568 |
| Erasca, Inc. | 0.1236 |
| NovelStem International Corp. | -0.8748 |
| Brainstorm Cell Therapeutics, Inc. | -0.1185 |
| Summit Therapeutics, Inc. | 0.0324 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.074B |
| Total Liabilities (Quarterly) | 49.35M |
| Shareholders Equity (Quarterly) | 1.025B |
| Current Ratio | 50.82 |
| Net Debt Paydown Yield | 0.02% |